Wall Street Experts
ver. ZuMIgo(08/25)
Tango Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 43
EBIT TTM (mln): -140
| index |
0 |
1 |
2 |
3 |
4 |
5 |
| Rok finansowy |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
25 |
8 |
37 |
25 |
37 |
42 |
| Przychód Δ r/r |
0.0% |
-68.9% |
383.8% |
-32.9% |
46.9% |
15.2% |
| Marża brutto |
-27.6% |
78.8% |
94.7% |
83.8% |
93.4% |
100.0% |
| EBIT (mln) |
-15 |
-52 |
-58 |
-111 |
-114 |
-146 |
| EBIT Δ r/r |
0.0% |
244.3% |
11.5% |
90.9% |
2.8% |
27.5% |
| EBIT (%) |
-61.5% |
-681.8% |
-157.1% |
-446.8% |
-312.6% |
-346.1% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
-3 |
0 |
0 |
| EBITDA (mln) |
-15 |
-51 |
-58 |
-111 |
-112 |
-146 |
| EBITDA(%) |
-58.9% |
-672.4% |
-157.1% |
-446.8% |
-306.0% |
-346.1% |
| Podatek (mln) |
0 |
-0 |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-14 |
-52 |
-58 |
-108 |
-102 |
-130 |
| Zysk netto Δ r/r |
0.0% |
268.0% |
12.3% |
85.8% |
-5.9% |
28.1% |
| Zysk netto (%) |
-57.2% |
-677.4% |
-157.2% |
-435.1% |
-278.5% |
-309.7% |
| EPS |
-1.57 |
-1.62 |
-0.94 |
-1.23 |
-1.08 |
-1.19 |
| EPS (rozwodnione) |
-1.57 |
-1.62 |
-0.94 |
-1.23 |
-1.08 |
-1.19 |
| Ilośc akcji (mln) |
9 |
32 |
62 |
88 |
95 |
109 |
| Ważona ilośc akcji (mln) |
9 |
32 |
62 |
88 |
95 |
109 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |